TY - JOUR
T1 - Effect of steroid on hyperoxia-induced ICAM-1 expression in pulmonary endothelial cells
AU - Suzuki, Yukio
AU - Nishio, Kazumi
AU - Takeshita, Kei
AU - Takeuchi, Osamu
AU - Watanabe, Kenji
AU - Sato, Nagato
AU - Naoki, Katsuhiko
AU - Kudo, Hiroyasu
AU - Aoki, Takuya
AU - Yamaguchi, Kazuhiro
PY - 2000/2
Y1 - 2000/2
N2 - Intercellular adhesion molecule-1 (ICAM-1) of the vascular endothelium plays a key role in the development of pulmonary oxygen toxicity. We studied the effect of steroid on hyperoxia-induced ICAM-1 expression using cultured endothelial cells in vitro. Human pulmonary artery endothelial cells (HPAECs) were cultured to confluence, and then the monolayers were exposed to either control (21% O2-5% CO2) or hyperoxic (90% O2-5% CO2) conditions with and without a synthetic glucocorticoid, methylprednisolone (MP). MP reduced hyperoxia-induced ICAM-1 and ICAM-1 mRNA expression in a dose-dependent manner. Neutrophil adhesion to hyperoxia-exposed endothelial cells was also inhibited by MP treatment. In addition, MP attenuated hyperoxia-induced H2O2 production in HPAECs as assessed by flow cytometry. An electrophoretic mobility shift assay demonstrated that hyperoxia activated nuclear factor-κB (NF-κB) but not activator protein-1 (AP-1) and that MP attenuated hyperoxia-induced NF-κB activation dose dependently. With Western immunoblot analysis, IκB-α expression was decreased by hyperoxia and increased by MP treatment. These results suggest that MP downregulates hyperoxia-induced ICAM-1 expression by inhibiting NF-κB activation via increased IκB-α expression.
AB - Intercellular adhesion molecule-1 (ICAM-1) of the vascular endothelium plays a key role in the development of pulmonary oxygen toxicity. We studied the effect of steroid on hyperoxia-induced ICAM-1 expression using cultured endothelial cells in vitro. Human pulmonary artery endothelial cells (HPAECs) were cultured to confluence, and then the monolayers were exposed to either control (21% O2-5% CO2) or hyperoxic (90% O2-5% CO2) conditions with and without a synthetic glucocorticoid, methylprednisolone (MP). MP reduced hyperoxia-induced ICAM-1 and ICAM-1 mRNA expression in a dose-dependent manner. Neutrophil adhesion to hyperoxia-exposed endothelial cells was also inhibited by MP treatment. In addition, MP attenuated hyperoxia-induced H2O2 production in HPAECs as assessed by flow cytometry. An electrophoretic mobility shift assay demonstrated that hyperoxia activated nuclear factor-κB (NF-κB) but not activator protein-1 (AP-1) and that MP attenuated hyperoxia-induced NF-κB activation dose dependently. With Western immunoblot analysis, IκB-α expression was decreased by hyperoxia and increased by MP treatment. These results suggest that MP downregulates hyperoxia-induced ICAM-1 expression by inhibiting NF-κB activation via increased IκB-α expression.
KW - Glucocorticoid
KW - Inhibitory protein IκB-α
KW - Intercellular adhesion molecule-1
KW - Nuclear factor-κB
UR - http://www.scopus.com/inward/record.url?scp=0034055312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034055312&partnerID=8YFLogxK
U2 - 10.1152/ajplung.2000.278.2.l245
DO - 10.1152/ajplung.2000.278.2.l245
M3 - Review article
C2 - 10666107
AN - SCOPUS:0034055312
SN - 1040-0605
VL - 278
SP - L245-L252
JO - American Journal of Physiology - Lung Cellular and Molecular Physiology
JF - American Journal of Physiology - Lung Cellular and Molecular Physiology
IS - 2 22-2
ER -